Ligand Down 20% Since August 1; What's The Street Thinking?

By: via Benzinga
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) hit a 52-week high of $139.79 at the beginning of August. Since then, the stock has been ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.